EnWave 2026 Third Quarter Consolidated Interim Financial Results

August 21, 2026

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the third quarter ended June 30, 2026.  

特に断りのない限り、数値はすべて千単位でCAD表示。

  • Reported Q3 2026 revenue of $3,313 an increase of $569 compared to the same period in the prior year. The increase was primarily driven by the sale of a large- scale machine that had been fully fabricated and held in inventory in prior periods and higher royalties.
  • Reported royalties, excluding exclusivity payments (“Base Royalties”), for Q3 2026 of $536, an increase of $104, or 24% relative to the comparable period in the prior year. Royalties increased due to higher product sales and partner production for the quarter.
  • Gross margin for the three months ended Q3 2026 was 25% compared to 19% for the three months ended Q3 2025. The increase in margin was primarily attributable to lower fabrication costs resulting from fewer large-scale machines on contract as compared to the prior quarter.
  • Reported a decrease in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $205 for Q3 2026 relative to the comparable period in the prior year, with the decrease primarily related to lower personnel and third-party commission costs offset by higher professional development fees and tradeshow attendance.
  • Reported an Adjusted EBITDA(1) loss of $93 for Q3 2026, a $482 improvement from the prior year, driven by large-scale equipment sale and lower SG&A expenses, including R&D.

連結業績:

($ ‘000s)Three months ended June 30,Nine months ended June 30,
20262025Change %20262025Change %
Revenues3,3132,74421%6,0727,610(20%)
Direct costs(2,501) (2,209)(13%)(4,258) (5,526)23%
   Gross margin81253552%1,8142,084(13%)
Operating expenses      
General and administration394532(26%)1,4391,541(7%)
Sales and marketing439485(9%)1,4521,4073%
Research and development367388(5%)1,2541,12412%
 1,2001,405(15%)4,1454,0722%
Net loss – continuing operations(465)(1,162)60%(2,722)(2,462)(11%)
Net (loss) income – discontinued operations(9)100%(6)1,109(101%)
Adjusted EBITDA(1) loss(93)(575)84%(1,453)(1,098)(32%)
Loss per share:      
Continuing operations – basic and diluted   $ 0.00   $ (0.01) $ (0.02)$ (0.02) 
Discontinued operations – basic and diluted   $ 0.00   $ 0.00   $ 0.00  $ 0.01 
Basic and diluted   $ 0.00   $ (0.01)   $ (0.02)  $ (0.01) 

Note: (1) Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Key Financial Highlights for the Nine Months Ended June 30, 2026 (expressed in 000’s)

  • Reported revenue of $6,072 a decrease of $1,538 relative to the comparable period in the prior year. The decrease was primarily related to fewer machine sales.  
  • Reported Base Royalties of $1,470, an increase of $139 or 10% relative to the comparative period in the prior year. Reported total royalty revenues of $1,628, an increase of $163 or 10% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
  • Reported a $73 increase in SG&A costs for the nine months ended June 30, 2026, primarily due to higher sales personnel, patent maintenance, legal fees associated with general business activities, and recruitment costs. Prior-year financing-related legal costs were capitalized as part of the transaction.
  • Reported an Adjusted EBITDA(1) loss of $1,453 for the nine months ended June 30, 2026, a decrease of $355 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q3 2026 and Subsequently:

  • Signed an Equipment Purchase Agreement with Procescir S.A. de C.V. for the purchase of second 120kW REVTM machine.
  • Signed a Technology Evaluation and License Option Agreement with Swiss Cannabis Selection AG.
  • Signed a Technology Evaluation and License Option Agreement with one of the world’s largest multinational food companies.
  • Signed a Commercial Licence Agreement and Equipment Purchase Agreement for a 10kW REVTM machine with The Dry Hub (“DryHub”), an Egyptian food processing Company.
  • Signed a Research and Development License Agreement with Rhizome Food and Farming LLC (“Rhizome”), a North American food Company led by renowned chef Dan Barber. Rhizome acquired a 3.6kW REVTM machine for commercial and product development.
  • Subsequent to the quarter, the Company signed Research and Development License Agreement with the University of Limerick (“Limerick”) in Ireland. Limerick acquired a small-scale REVTM machine to support research and product development.

非IFRS財務指標:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery, non-recurring income and expenses,  restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

 Three months ended June 30,Nine months ended June 30
 ($ ‘000s) 20262025 20262025
Net loss after income tax(465)(1,171)(2,728)(1,353)
      Amortization and depreciation295295878890
      Stock-based compensation7659246330
      Foreign exchange (gain) loss(96)194(83)53
      Finance income(14)(26)(48)(103)
      Finance expense11165302205
     Non-recurring income(26)(11)
   Discontinued operations96(1,109)
Adjusted EBITDA(93)(575)(1,453)(1,098)

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.

エンウェーブについて

EnWave社は、真空マイクロ波脱水の革新と応用の世界的リーダーです。EnWave社は、BC州デルタに本社を置き、強固な知的財産ポートフォリオを開発し、放射エネルギー真空(REV™)技術を完成させ、革新的なアイデアを、食品、製薬、大麻産業用の、実績のある、一貫した、拡張可能な乾燥ソリューションに変えました。

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

エンウェーブの戦略は、凍結乾燥、ラック乾燥、風乾よりも、より良く、より速く、より経済的に乾燥させ、エキサイティングな新製品を生産し、最適な水分レベルに最大7倍速く到達し、製品の味、食感、色、栄養価を向上させるという次のようなメリットを享受したいと考える食品製造業者と、ロイヤリティを伴う商業ライセンスを締結することである。

詳しくはEnWave.netをご覧ください。

エンウェーブ・コーポレーション

ブレント・チャールトン CFA

社長兼CEO

詳細はこちら:

ブレント・チャールトン、CFA、社長兼CEO、電話:+1 (778) 378-9616
E-mail:bcharleton@enwave.net      

Nav Dhami, CPA, CFO at +1 (604) 260-4854 
E-mail: ndhami@enwave.net 

将来予測情報に関する記述のセーフハーバー:本プレスリリースには、経営陣の期待、見積もり、予測に基づく将来の見通しに関する情報が含まれている場合があります。当社の成長戦略、製品開発、市場での地位、予想される支出、クロージング後に期待されるシナジー効果に関する記述を含め、将来に対する期待や予測に言及する記述はすべて、将来の見通しに関する記述です。本リリースで言及されている第三者の主張はすべて、その正確性を保証するものではありません。本リリースに記載されている市場情報に関する第三者による言及は、当社が独自に一次調査を行ったものではないため、その正確性を保証するものではありません。これらの記述は将来の業績を保証するものではなく、多くのリスク、不確実性および仮定を含んでいます。当社は、実際の結果と大きく異なる可能性のある重要な要因を特定するよう努めましたが、予想、見積りまたは意図したとおりの結果とならないその他の要因が存在する可能性があります。実際の結果や将来の事象は、かかる記述で予想されたものとは大きく異なる可能性があるため、かかる記述が正確であることを保証するものではありません。したがって、読者は将来の見通しに関する記述を過度に信頼すべきではありません。

TSXベンチャー取引所およびその規制サービスプロバイダー(この用語はTSXベンチャー取引所の方針で定義されています)は、本リリースの妥当性または正確性について責任を負いません。